Nonlinear correlation between serum vitamin D levels and the incidence of endometrial polyps in infertile women
article
OA: bronze
CC0
AI-generated summary
Serum vitamin D levels showed a nonlinear correlation with endometrial polyp incidence in infertile women, with deficiency identified as an independent risk factor.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
STUDY QUESTION: Are serum vitamin D levels associated with the incidence of endometrial polyps (EPs) in infertile patients? SUMMARY ANSWER: Serum 25(OH)D levels were nonlinearly correlated with the incidence of EPs in infertile women. WHAT IS KNOWN ALREADY: EPs are a common condition that may affect the receptivity of the endometrium in women of reproductive age. Vitamin D regulates cell proliferation and differentiation, apoptosis, angiogenesis, anti-inflammation, and immunomodulation, in addition to its well-known functions in balancing calcium and phosphorus. Previous studies have shown that vitamin D concentrations are associated with reproductive outcomes, and that low vitamin D levels are associated with the incidence of colorectal polyps and nasal polyps. There is little evidence regarding the relationship between EPs and serum vitamin D levels. STUDY DESIGN, SIZE, DURATION: We conducted a cross-sectional study using data from Guangdong Women and Children Hospital from January 2019 to October 2023, enrolling 3107 patients. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 3107 infertile patients who underwent hysteroscopy were included in this study; 642 patients had endometrial polyps and 2465 had a normal uterine cavity. Hysteroscopy findings included risk of EPs, polyp size, percentage of multiple polyps, and incidence of chronic endometritis (CE). Serum vitamin D were assessed by measuring total 25(OH)D using chemiluminescence. According to international guideline recommendations for vitamin D deficiency, patients were divided into two groups: the <50 nmol/l group and the ≥50 nmol/l group. Univariable and multivariable logistic regression models, stratified analyses, and smooth curve fitting were used to examine the relationship between serum 25(OH)D levels and risk of EPs. MAIN RESULTS AND THE ROLE OF CHANCE: Of all patients, 23.8% (740/3107) were vitamin D deficient (<50 nmol/l). The incidence of EPs was significantly higher in the 25(OH)D < 50 nmol/l group than in the ≥50 nmol/l group (24.9% vs 19.3%; P = 0.001). However, there were no differences in polyp size, proportion of multiple polyps, and presence of CE between the two groups. After controlling for confounders, 25(OH)D ≥ 50 nmol/l (compared with <50 nmol/l) was negatively associated with risk of EPs (adjusted OR, 0.733; 95% CI, 0.598-0.898). Other variables that had an impact on polyp incidence included BMI, type of infertility, CA125, and CD138-positive plasma cells. In addition, a linear regression model between age and serum 25(OH)D levels showed a positive linear association. Subgroup analyses were performed for different age groups, and the risk of EPs was significantly higher in the 25(OH)D < 50 nmol/l group than in the ≥50 nmol/l group, both in the younger subgroup (23.8% vs 19.1%) and in the older subgroup (28.0% vs 19.9%). The smooth curve fitting model showed a nonlinear correlation between 25(OH)D levels and risk of EPs (nonlinear P-value = 0.020), with an optimal threshold of 51.8 nmol/l for 25(OH)D levels. Moreover, subgroup smooth curve fitting models showed a nonlinear correlation between 25(OH)D levels and polyp risk in patients aged <35 years (nonlinear P-value = 0.010), whereas a linear correlation between 25(OH)D levels and polyp risk was found in patients aged ≥35 years (nonlinear P-value = 0.682). LIMITATIONS, REASONS FOR CAUTION: Caution should be exercised in interpreting our findings as this is a correlational study and causality cannot be inferred from our results. In addition, because of strict inclusion and exclusion criteria, our results may not be generalizable to unselected populations, including premenopausal women or women of other races. WIDER IMPLICATIONS OF THE FINDINGS: This study demonstrated for the first time that vitamin D deficiency is an independent risk factor for the incidence of EPs in infertile patients. Identifying modifiable risk factors (e.g. vitamin D deficiency) can help in the development of new strategies for treating polyps or to protect against polyp development. Further clinical intervention trials and laboratory studies are needed to evaluate the effect of vitamin D on the development of EPs and to elucidate the mechanisms. STUDY FUNDING/COMPETING INTEREST(S): The study was funded by the National Natural Science Foundation of China (82101718) and Natural Science Foundation of Guangdong Province, China (2022A1515010776). No competing interest was involved in this study. TRIAL REGISTRATION NUMBER: N/A.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (70)
- Cellular immune environment in endometrial polyps via openalex
- Replete vitamin D stores predict reproductive success following in vitro fertilization via openalex
- Uterine polyps, adenomyosis, leiomyomas, and endometrial receptivity via openalex
- Vitamin D and assisted reproductive treatment outcome: a systematic review and meta-analysis via openalex
- Vitamin D and uterine fibroid growth, incidence, and loss: a prospective ultrasound study via openalex
- W1965929765 via openalex
- W1972422162 via openalex
- W1998086267 via openalex
- W2028151326 via openalex
- W2029288107 via openalex
- W2029688057 via openalex
- W2030506754 via openalex
- W2048255553 via openalex
- W2055554149 via openalex
- W2059886617 via openalex
- W2060871109 via openalex
- W2067883883 via openalex
- W2068855200 via openalex
- W2072004401 via openalex
- W2072108911 via openalex
- W2072975437 via openalex
- W2073427932 via openalex
- W2081529984 via openalex
- W2107818459 via openalex
- W2116262309 via openalex
- W2124070987 via openalex
- W2124580054 via openalex
- W2129456605 via openalex
- W2130462088 via openalex
- W2134193229 via openalex
- W2135022145 via openalex
- W2136581059 via openalex
- W2153059487 via openalex
- W2153296188 via openalex
- W2159688447 via openalex
- W2163003695 via openalex
- W2167589457 via openalex
- W2175923714 via openalex
- W2182400851 via openalex
- W2304890332 via openalex
- W2565375500 via openalex
- W2781680885 via openalex
- W2802248829 via openalex
- W2808116449 via openalex
- W2809584125 via openalex
- W2810529814 via openalex
- W2969480666 via openalex
- W2984382213 via openalex
- W3090160861 via openalex
- W3132845649 via openalex
- W3137216030 via openalex
- W4211046201 via openalex
- W4244978989 via openalex
- W4245940288 via openalex
- W4249601304 via openalex
- W4283068796 via openalex
- W4386746049 via openalex
- W6601056837 via openalex
- W6636518258 via openalex
- W6639226434 via openalex
- W6664761333 via openalex
- W6667774643 via openalex
- W6679816112 via openalex
- W7074217230 via openalex
- W27561925 via openalex
- doi:10.12891/ceog3094.2016 via openalex
- W68409221 via openalex
- W1563558118 via openalex
- W1575848068 via openalex
- W1616778816 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK